Neutrophils in asthma

Current Allergy and Asthma Reports

Volumn 7, Issue 6, 2007, Pages 464-468

  MacDowell, Ana L ^a   Peters, Stephen P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GELATINASE B; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEUKOCYTE ELASTASE; NITROGEN DIOXIDE; OZONE; PLACEBO; STEROID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE;

ACUTE LUNG INJURY; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE ACTIVATION; LUNG BIOPSY; LUNG LAVAGE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NEUTROPHILIA; NONHUMAN; POLLUTANT; REVIEW; SINGLE DRUG DOSE; SMOKING; SPUTUM ANALYSIS;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEUTROPHIL ACTIVATION; NEUTROPHILS; RESPIRATORY SYSTEM;

EID: 35448987005     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0071-6     Document Type: Review

References (48)

1. Turner MO, Hussack P, Sears MR, et al.: Exacerbations of asthma without sputum eosinophilia. Thorax 1995, 50:1057-1061.
2. Douwes J, Gibson P, Pekkanen J, Pearce N: Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002, 57:643-648.
3. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma. Chest 2001, 119:1329-1336.
4. Green RH, Brightling CE, Woltmann G, et al.: Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002, 57:875-879.
5. Sur S, Crotty TB, Kephart GM, et al.: Sudden onset fatal asthma: a distinct entity with few eosinophils and relatively more eosinophils in the airway submucosa? Am Rev Respir Dis 1993, 148:713-719.
6. Yasui K, Kobayashi N, Yamazaki T, et al.: Neutrophilic inflammation in childhood bronchial asthma. Thorax 2005, 60:704-707.
7. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER: Is the neutrophil the key effector cell in severe asthma? Thorax 2005, 60:529-530.
8. Norzila MZ, Fakes K, Henry RL, et al.: Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000, 161:769-774.
9. Fahy JV, Kim KW, Liu J, Boushey HA: Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995, 95:843-852.
10. Lamblin C, Gosset P, Tillie-Leblond I, et al.: Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998, 157:394-402.
11. Smith HR, Larsen GL, Cherniack RM et al.: Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol 1992, 89:1076-1084.
12. Teran LM, Carroll M, Frew AJ, et al.: Neutrophil influx and interleukin-8 release after segmental allergen or saline challenge in asthmatics. Int Arch Allergy Immunol 1995, 107:374-375.
13. Casale TB, Costa JJ, Galli SJ: TNF alpha is important in human lung allergic reactions. Am J Respir Cell Mol Biol 1996, 15:35-44.
14. Gounni AS, Lamkhioued B, Koussih L, et al.: Human neutrophils express the high-affinity receptor for immunoglobulin E (FcæRI): role in asthma. FASEB J 2001, 15:940.
15. Coffey MJ, Wheeler CS, Gross KB, et al.: Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology 1996, 114:187-197.
16. Fahy JV, Wong HH, Liu JT, Boushey HA. Analysis of induced sputum after air and ozone exposures in healthy subjects. Environ Res 1995, 70:77-83.
17. Barck C, Lundahl J, Halldén G, Bylin G: Brief exposures to NO2 augment the allergic inflammation in asthmatics. Environ Res 2005, 97:58-66.
18. Adelroth E, Hedlund U, Blomberg A, et al.: Airway inflammation in iron ore miners exposed to dust and diesel exhaust. Eur Respir J 2006, 27:714-719.
19. Moore WC, Peters SP: Severe asthma: an overview. J Allergy Clin Immunol 2006, 117:487-494.
20. Jatakanon A, Uasuf C, Maziak W, et al.: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
21. Silvestri M, Bontempelli M, Giacomelli M, et al.: High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation? Clin Exp Allergy 2006, 36:1373-1381.
22. Wenzel SE, Szefler SJ, Leung DY, et al.: Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997, 156:737-743.
23. Louis R, Lau LC, Bron AO, et al.: The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000, 161:9-16.
24. Wenzel SE, Schwartz LB, Langmack EL, et al.: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999, 160:1001-1008.
25. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003, 22:470-477.
26. Di Stefano A, Capelli A, Lusuardi M, et al.: Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998, 158:1277-1285.
27. Nguyen LT, Lim S, Oates T, Chung KF: Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. Respir Med 2005, 99:200-207.
28. Miranda C, Busacker A, Balzar S, et al.: Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004, 113:101-108.
29. Martin RJ, Cicutto LC, Smith HR, et al.: Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991, 143:351-357.
30. Pascual RM, Peters SP: Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 2005, 116:477-486.
31. Fava RA, Olsen NJ, Postlethwaite AE, et al.: Transforming growth factor beta 1 (TGF- 1) induced neutrophil recruitment to synovial tissues: implications for TGF- -driven synovial inflammation and hyperplasia. J Exp Med 1991, 173:1121-1132.
32. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995, 16:21-26.
33. Fava RA, Casey TT, Wilcox J, et al.: Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules. Blood 1990, 76:1946-1955.
34. Batra V, Musani AI, Hastie AT, et al.: Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004, 34:437-444.
35. Chu HW, Trudeau JB, Balzar S, Wenzel SE: Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000, 106:1115-1123.
36. Rajah R, Nachajon RV, Collins MH, et al.: Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 1999, 20:199-208.
37. Stetler-Stevenson WG: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 1999, 103:1237-1241.
38. Shipley JM, Wesselschmidt RL, Kobayashi DK, et al.: Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 1996, 93:3942-3946.
39. Shipley JM, Doyle GA, Fliszar CJ, et al.: The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases: role of the fibronectin type II-like repeats. J Biol Chem 1996, 271:4335-4341.
40. Legrand C, Gilles C, Zahm JM, et al.: Airway epithelial cell migration dynamics: MMP-9 role in cell-extracellular matrix remodeling. J Cell Biol 1999, 146:517-529.
41. Cataldo D, Munaut C, Noel A, et al.: MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000, 123:259-267.
42. Simpson JL, Scott RJ, Boyle MJ, Gibson PG: Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 2005, 172:559-565.
43. Mattos W, Lim S, Russell R, et al.: Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002, 122:1543-1552.
44. Vignola AM, Bonanno A, Mirabella A, et al.: Increased levels of elastase and alpha 1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998, 157:505-511.
45. Bousquet J, Lacoste JY, Chanez P, et al.: Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med 1996, 153:1648-1654.
46. Nakamaran H, Yoshimura K, McElvaney NG, Crystal RG: Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992, 89:1478-1484.
47. Cox G: Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol 1995, 154:4719-4725.
48. ten Brinke A, Zwinderman AH, Sterk PJ, et al.: "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004, 170:601-605.